Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (40)

« Back to Publications

Secular Trends in the Use of Valproate-Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study.

Bellas L. et al, (2025), Pharmacoepidemiol Drug Saf, 34

Clusters of post-acute COVID-19 symptoms: a latent class analysis across 9 databases and 7 countries.

López-Güell K. et al, (2025), J Clin Epidemiol, 185

Development of the ECHOES national dataset: a resource for monitoring post-acute and long-term COVID-19 health outcomes in England.

Allen H. et al, (2025), Front Public Health, 13

Trends in prescription opioid use in Europe: A DARWIN EU® multinational cohort study including seven European countries.

Xie J. et al, (2025), Front Pharmacol, 16

Standardised and Reproducible Phenotyping Using Distributed Analytics and Tools in the Data Analysis and Real World Interrogation Network (DARWIN EU).

Dernie F. et al, (2024), Pharmacoepidemiol Drug Saf, 33

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data.

Xie J. et al, (2024), EClinicalMedicine, 77

Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones.

Guo Y. et al, (2024), Pharmacoepidemiol Drug Saf, 33

Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.

Mercadé-Besora N. et al, (2024), Arthritis Care Res (Hoboken), 76, 1173 - 1178

Calculating daily dose in the Observational Medical Outcomes Partnership Common Data Model.

Burkard T. et al, (2024), Pharmacoepidemiol Drug Saf, 33

Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes.

Xie J. et al, (2024), Nat Commun, 15

Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway.

Trinh NT. et al, (2024), Lancet Respir Med, 12, e33 - e34

The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications.

Mercadé-Besora N. et al, (2024), Heart, 110, 635 - 643

The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia.

Català M. et al, (2024), Lancet Respir Med, 12, 225 - 236

Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation.

Català M. et al, (2024), Int J Epidemiol, 53

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.

Barclay NL. et al, (2024), Front Oncol, 14

Load More